ETF甄选 | 三大指数震荡回调，创新药、影视、软件等相关ETF逆势走强

Market Overview - The market experienced a decline on October 31, 2025, with all three major indices closing lower: Shanghai Composite Index down 0.81%, Shenzhen Component Index down 1.14%, and ChiNext Index down 2.31% [1] Sector Performance - Biopharmaceuticals, chemical pharmaceuticals, and cultural media sectors showed the highest gains, while insurance, small metals, and semiconductors faced the largest declines [1] ETF Performance - Innovation drugs, film and television, and software-related ETFs performed well, likely driven by relevant news [2] Biopharmaceutical Sector - The National Medical Insurance negotiation began on October 30, 2025, introducing a "commercial insurance innovative drug catalog" mechanism, which includes innovative drugs with high clinical value that are not yet part of the basic medical insurance catalog [2] - According to Industrial Securities, the ongoing business development (BD) in the innovative drug sector is expected to sustain the current industry prosperity, with a focus on "innovation + internationalization" [2] Cultural Industry - Cultural enterprises reported a net profit of 909.3 billion yuan in the first three quarters, a year-on-year increase of 14.2%, with an operating income profit margin of 8.30% [2] - The cultural industry is experiencing a transformation driven by AI-generated content (AIGC), which is expected to create new opportunities in the industry [3] Software Industry - The software and information technology service industry in China saw a revenue of 1,111.26 billion yuan in the first three quarters, reflecting a year-on-year growth of 13.0% [4] - Longjiang Securities highlighted the importance of achieving complete autonomy in key areas, particularly in the domestic operating system and chip industries, as a response to global technological competition [4]